Inventor · disambiguated record
Andrew W. Drake
Also filed as: DRAKE ANDREW · DRAKE ANDREW W · DRAKE ANDREW WALLING
27 granted patents·11 pending applications·205 citations·filing 2011–2025
97Inventor score
Files withCOMPUGEN LTD19TAKEDA PHARMACEUTICALS CO9TAKEDA PHARMACEUTICAL2THERANOS IP CO LLC2DEKA PRODUCTS LP1
Top patents by PatentIndex Score
38 records- 0198US8362211B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICAL·Filed 2011·Granted Jan 29, 2013·71 cites·12 claims
- 0297US11414496B2Anti-CD38 binding domainsMILLENNIUM PHARM INC·Filed 2020·Granted Aug 16, 2022·4 cites·21 claims
- 0395US12312404B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2023·Granted May 27, 2025·1 cites·16 claims
- 0495US9676869B2Conjugated anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jun 13, 2017·12 cites·20 claims
- 0595US9464981B2Systems and methods for sample use maximizationTHERANOS INC·Filed 2014·Granted Oct 11, 2016·11 cites·19 claims
- 0694US11623955B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2020·Granted Apr 11, 2023·3 cites·33 claims
- 0794US10494444B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Dec 3, 2019·8 cites·10 claims
- 0894US10336833B2Conjugated anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Jul 2, 2019·9 cites·30 claims
- 0994US9714289B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2016·Granted Jul 25, 2017·14 cites·20 claims
- 1093US10124061B2Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2017·Granted Nov 13, 2018·9 cites·20 claims
- 1193US2025171561A1Anti-cd38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 1292US10751415B2Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2017·Granted Aug 25, 2020·6 cites·22 claims
- 1392US10213505B2Anti-TIGIT anibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2018·Granted Feb 26, 2019·6 cites·2 claims
- 1492US8926969B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICAL·Filed 2012·Granted Jan 6, 2015·14 cites·17 claims
- 1591US11220542B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2016·Granted Jan 11, 2022·3 cites·42 claims
- 1690US10227408B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2016·Granted Mar 12, 2019·6 cites·20 claims
- 1790US9790285B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Oct 17, 2017·7 cites·24 claims
- 1890US9102744B2Conjugated anti-CD38 antibodiesELIAS KATHLEEN ANN·Filed 2011·Granted Aug 11, 2015·13 cites·17 claims
- 1988US10557786B2Systems and methods for sample use maximizationTHERANOS IP CO LLC·Filed 2016·Granted Feb 11, 2020·2 cites·20 claims
- 2086US11199489B2Systems and methods for sample use maximizationTHERANOS IP CO LLC·Filed 2015·Granted Dec 14, 2021·3 cites·30 claims
- 2185US12209138B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Jan 28, 2025·0 cites·17 claims
- 2284US2025333503A1Anti-pvrig antibodies and methods of useCOMPUGEN LTD·Filed 2025·Application pending·0 cites
- 2383US11701424B2Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2020·Granted Jul 18, 2023·1 cites·30 claims
- 2481US2024025973A1Pvrig polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 2579US2024139318A1Anti-tigit antibodies, anti-pvrig antibodies and combinations thereofCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 2678US11434304B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 6, 2022·0 cites·28 claims
- 2778US10550173B2PVRIG polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2016·Granted Feb 4, 2020·2 cites·10 claims
- 2876US12312411B2Anti-CD38 binding domainsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted May 27, 2025·0 cites·20 claims
- 2975US11795220B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2020·Granted Oct 24, 2023·0 cites·24 claims
- 3072US2020031951A1Conjugated anti-cd38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2019·Application pending·0 cites
- 3172US2024287174A1Hide1 compositions and methodsCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 3272US2022252503A1Systems and methods for sample use maximizationLABRADOR DIAGNOSTICS LLC·Filed 2021·Application pending·0 cites
- 3370US11795209B2PVRIG polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2020·Granted Oct 24, 2023·0 cites·15 claims
- 3468US10351625B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2018·Granted Jul 16, 2019·0 cites·34 claims
- 3562US2025195733A1Medical treatment system and methods using a plurality of fluid linesDEKA PRODUCTS LP·Filed 2023·Application pending·0 cites
- 3659US2012309636A1Systems and methods for sample use maximizationGIBBONS IAN·Filed 2012·Application pending·0 cites
- 3748US2018305451A1Hide1 compositions and methodsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 3846US2019382477A1Anti-pvrig/anti-tigit bispecific antibodies and methods of useCOMPUGEN LTD·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →